Bioanalysis and enantioseparation of dl-carnitine in human plasma by the derivatization approach
Related Experiment Video
Updated: Apr 1, 2026
Free Radicals in Chemical Biology: from Chemical Behavior to Biomarker Development
Published on: April 15, 2013
Vinod Kumar Vashistha1, Ravi Bhushan1
1Department of Chemistry, Indian Institute of Technology Roorkee, Roorkee 247667, India.
Background:
L-carnitine is an over the counter drug, used to treat disorders like cardiomyopathy, skeletal myopathy, hypoglycemia and hyperammonemia. Preparations containing D-carnitine should be avoided by dialysis patients because it has toxic influence on biochemical processes by inhibiting the carnitine acetyltransferase. Therefore, it is of utmost importance to assess and control the content of D-carnitine.
Methods:
A HPLC method was developed and validated for determination and enantiomeric resolution of DL-carnitine in human plasma by derivatization approach. (S)-Naproxen-based three derivatizing reagents were synthesized and applied.
Conclusion:
The limit of detection values were found to be 1.26 and 1.35 ng ml(-1) for the two isomers. The method is simple, reproducible, and can be used for routine analysis in laboratories for control of enantiomeric purity of carnitine.
More Related Videos
09:26Cellular Lipid Extraction for Targeted Stable Isotope Dilution Liquid Chromatography-Mass Spectrometry Analysis
Published on: November 17, 2011
13:35A Convenient Method for Extraction and Analysis with High-Pressure Liquid Chromatography of Catecholamine Neurotransmitters and Their Metabolites
Published on: March 1, 2018